[ad_1] Etsy shares tumbled on Tuesday, falling 6.9% to $48.81 amid a broader selloff across the Internet Retail sector that dragged multiple peers into the red. The e-commerce marketplace saw 2.3M shares change hands as the sector-wide weakness pulled its…
[ad_1] How much would a Stocks and Shares ISA have made in the last five years? Half a decade now takes us back to 2021 â hard as that may be to believe! And that means we are covering the…
[ad_1] The Trade Desk plunged 6.6% on Tuesday as investors reacted to significant insider selling by a top executive. Shares of the advertising technology company fell to $22.36 on heavy volume of 20.1M shares, cutting the firm’s market cap to…
[ad_1] What a market! Amid increasingly unpredictable and erratic US policymaking â as well as weak economic growth here in the UK â it has been a volatile few days for investors. My initial instinct is to continue looking for…
[ad_1] Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s lead asset, abdakibart, is currently advancing through a Phase 2 clinical trial for hidradenitis suppurativa. Key Financial Figures For…
[ad_1] Passive income investors have been licking their lips recently as the stock market entered correction territory. How do I know? Well, Legal & General, Primary Health Properties (LSE:PHP) and Taylor Wimpey have been three of the four most popular shares…
[ad_1] Company Overview Surrozen is a biotechnology company developing targeted therapeutics that harness Wnt signaling to address sight-threatening ophthalmic conditions. Key Financial Figures For the full year 2025, Surrozen reported total revenue of $3.5 million, generated entirely from related-party research…
[ad_1] Real estate investment trusts (REITs) can be a great way to source a passive income over time. Sector rules state that at least 90% of annual rental profits be paid out to shareholders. That’s in exchange for helpful breaks…
[ad_1] SMTI|EPS -$0.13 vs $0.11 est (-215.9%)|Rev $27.5M|Net Loss $1.1M Stock $18.34 (-0.2%) Disappointing quarter. Sanara MedTech Inc. (SMTI) reported Q4 2025 GAAP earnings of -$0.13 per share, falling short of the $0.11 consensus estimate by 215.9%. The medical instruments…
[ad_1] It’s been a tough few weeks for the FTSE 100 and FTSE 250‘s housebuilding shares. Bellway (LSE:BWY) for instance has sunk 32% in value over the past month, reflecting worries over future interest rates. In fact, it’s down a…